Study author
|
RPL cases
|
Healthy control
|
P-HWE
|
MAF
|
---|
GG
|
GA
|
AA
|
G
|
A
|
GG
|
GA
|
AA
|
G
|
A
|
---|
Souza et al. [34]
|
52
|
4
|
0
|
108
|
4
|
378
|
6
|
0
|
762
|
6
|
0/87
|
0/007
|
Brenner et al. [35]
|
52
|
19
|
5
|
123
|
29
|
95
|
11
|
0
|
201
|
11
|
0/57
|
0/051
|
Wramsby et al. [36]
|
51
|
10
|
1
|
112
|
12
|
67
|
2
|
0
|
136
|
2
|
0/9
|
0/014
|
Murphy et al. [52]
|
39
|
2
|
0
|
80
|
2
|
527
|
13
|
0
|
1067
|
13
|
0/77
|
0/012
|
Pihusch et al. [33]
|
94
|
8
|
0
|
196
|
8
|
117
|
11
|
0
|
245
|
11
|
0/61
|
0/042
|
Younis et al.
|
63
|
12
|
3
|
138
|
18
|
131
|
8
|
0
|
270
|
8
|
0/72
|
0/028
|
Foka et al. [14]
|
65
|
15
|
0
|
145
|
15
|
96
|
4
|
0
|
196
|
4
|
0/83
|
0/02
|
Rai et al.
|
1037
|
72
|
2
|
2146
|
76
|
138
|
12
|
0
|
288
|
12
|
0/6
|
0/04
|
Carp et al.
|
104
|
4
|
0
|
212
|
4
|
77
|
5
|
0
|
159
|
5
|
0/77
|
0/03
|
Finan et al. [38]
|
65
|
38
|
7
|
168
|
52
|
56
|
11
|
0
|
123
|
11
|
0/46
|
0/082
|
Hohlagschwandtner et al.
|
130
|
15
|
0
|
275
|
15
|
97
|
4
|
0
|
198
|
4
|
0/83
|
0/019
|
Pauer et al. [39]
|
28
|
2
|
0
|
58
|
2
|
113
|
9
|
0
|
235
|
9
|
0/67
|
0/036
|
Mtiraoui et al.
|
116
|
24
|
6
|
256
|
36
|
93
|
6
|
0
|
192
|
6
|
0/75
|
0/03
|
Aksoy et al.
|
31
|
9
|
1
|
71
|
11
|
45
|
5
|
0
|
95
|
5
|
0/7
|
0/05
|
Mahjoub et al. [40]
|
152
|
40
|
8
|
344
|
56
|
189
|
11
|
0
|
389
|
11
|
0/68
|
0/027
|
Ulukus et al.
|
7
|
3
|
0
|
17
|
3
|
49
|
3
|
1
|
101
|
5
|
≤0.001
|
0/047
|
Sotiriadis et al.
|
94
|
5
|
0
|
193
|
5
|
99
|
3
|
0
|
201
|
3
|
0/88
|
0/014
|
Mohammad et al. [21]
|
25
|
10
|
0
|
60
|
10
|
41
|
4
|
0
|
86
|
4
|
0/75
|
0/044
|
Altintas et al. [41]
|
105
|
9
|
0
|
219
|
9
|
172
|
13
|
0
|
357
|
13
|
0/62
|
0/035
|
Toth et al. [42]
|
138
|
13
|
0
|
289
|
13
|
145
|
12
|
0
|
302
|
12
|
0/61
|
0/038
|
Pasquier et al.
|
296
|
15
|
0
|
607
|
15
|
574
|
25
|
0
|
1173
|
25
|
0/6
|
0/02
|
Biswas et al. [43]
|
83
|
2
|
0
|
168
|
2
|
31
|
0
|
0
|
62
|
0
|
≤0.001
|
0
|
Lvanov et al.
|
133
|
19
|
1
|
285
|
21
|
93
|
7
|
0
|
193
|
7
|
0/71
|
0/035
|
Mukhopadhyay et al. [44]
|
80
|
4
|
0
|
164
|
4
|
80
|
0
|
0
|
160
|
0
|
≤0.001
|
0
|
Ciacci et al. [45]
|
38
|
1
|
0
|
77
|
1
|
70
|
2
|
0
|
142
|
2
|
0/9
|
0/013
|
Mohamed et al. [46]
|
6
|
12
|
2
|
24
|
16
|
19
|
1
|
0
|
39
|
1
|
0/9
|
0/025
|
Hussein et al. [47]
|
104
|
36
|
5
|
244
|
46
|
181
|
24
|
0
|
386
|
24
|
0/37
|
0/058
|
Serrano et al. [17]
|
95
|
5
|
0
|
195
|
5
|
95
|
5
|
0
|
195
|
5
|
0/79
|
0/025
|
Settin et al.
|
54
|
17
|
1
|
125
|
19
|
69
|
1
|
0
|
139
|
1
|
0/95
|
0/007
|
Dissanayake et al. [32]
|
196
|
4
|
0
|
396
|
4
|
195
|
5
|
0
|
395
|
5
|
0/85
|
0/012
|
Gazi et al.
|
50
|
6
|
1
|
106
|
8
|
43
|
4
|
0
|
90
|
4
|
0/76
|
0/042
|
Karata et al.
|
66
|
16
|
2
|
148
|
20
|
66
|
18
|
0
|
150
|
18
|
0/27
|
0/107
|
Mierla et al. [48]
|
260
|
21
|
2
|
541
|
25
|
95
|
5
|
0
|
195
|
5
|
0/79
|
0/025
|
Ozdemir et al. [49]
|
433
|
109
|
1
|
975
|
111
|
104
|
2
|
0
|
210
|
2
|
0/92
|
0/009
|
Torabi et al. [50]
|
87
|
12
|
1
|
186
|
14
|
96
|
4
|
0
|
196
|
4
|
0/83
|
0/02
|
Kaur et al.
|
102
|
4
|
1
|
208
|
6
|
573
|
15
|
0
|
1161
|
15
|
0/75
|
0/012
|
Parveen et al.
|
950
|
50
|
0
|
1950
|
50
|
488
|
12
|
0
|
988
|
12
|
0/78
|
0/012
|
Ardestani et al.
|
78
|
2
|
0
|
158
|
2
|
79
|
1
|
0
|
159
|
1
|
0/95
|
0/006
|
Cardona et al. [51]
|
92
|
1
|
0
|
185
|
1
|
205
|
1
|
0
|
411
|
1
|
0/97
|
0/002
|
Kazerooni et al. [52]
|
43
|
12
|
5
|
98
|
22
|
54
|
4
|
2
|
112
|
8
|
0.48
|
0.734
|
Baumann et al.
|
592
|
49
|
0
|
1233
|
49
|
145
|
12
|
0
|
302
|
12
|
0/61
|
0/038
|
Parand et al. [53]
|
72
|
15
|
3
|
159
|
21
|
38
|
6
|
0
|
82
|
6
|
0/62
|
0/068
|
Zonouzi et al. [54]
|
87
|
2
|
0
|
176
|
2
|
50
|
0
|
0
|
100
|
0
|
≤0.001
|
0
|
Dutra et al.
|
142
|
3
|
0
|
287
|
3
|
131
|
4
|
0
|
266
|
4
|
0/86
|
0/014
|
Isaoglu et al.
|
47
|
13
|
0
|
107
|
13
|
39
|
1
|
0
|
79
|
1
|
0/93
|
0/012
|
Pietropolli et al. [55]
|
168
|
18
|
0
|
354
|
18
|
125
|
4
|
0
|
254
|
4
|
0/85
|
0/015
|
Lino et al.
|
79
|
4
|
0
|
162
|
4
|
96
|
2
|
0
|
194
|
2
|
0/91
|
0/01
|
Sharma et al. [56]
|
36
|
40
|
2
|
112
|
44
|
77
|
1
|
0
|
155
|
1
|
0/95
|
0/006
|
Farahmand et al.
|
302
|
28
|
0
|
632
|
28
|
340
|
10
|
0
|
690
|
10
|
0/78
|
0/014
|
Kashif et al. [57]
|
53
|
3
|
0
|
109
|
3
|
56
|
0
|
0
|
112
|
0
|
≤0.001
|
0
|
Gonçalves et al. [58]
|
133
|
4
|
0
|
270
|
4
|
98
|
2
|
0
|
198
|
2
|
0/91
|
0/01
|
Khaniani et al. [59]
|
202
|
8
|
0
|
412
|
8
|
158
|
2
|
0
|
318
|
2
|
0/93
|
0/006
|
Eldeen et al.
|
0
|
72
|
24
|
72
|
120
|
0
|
94
|
2
|
94
|
98
|
≤0.001
|
0/51
|
Wolski et al. [60]
|
333
|
26
|
0
|
692
|
26
|
378
|
21
|
1
|
777
|
23
|
0/23
|
0/028
|
Elgari et al. [61]
|
56
|
4
|
0
|
116
|
4
|
74
|
6
|
0
|
154
|
6
|
0/72
|
0/037
|
Mahmutbegović et al. [62]
|
44
|
7
|
0
|
95
|
7
|
142
|
12
|
0
|
296
|
12
|
0/61
|
0/038
|
Wingeyer et al.
|
239
|
8
|
0
|
486
|
8
|
105
|
2
|
0
|
212
|
2
|
0/92
|
0/009
|
Jusić et al.
|
51
|
9
|
0
|
111
|
9
|
77
|
3
|
0
|
157
|
3
|
0/86
|
0/018
|
Taghi Kardi et al.
|
236
|
12
|
2
|
484
|
16
|
109
|
5
|
2
|
223
|
9
|
≤0.001
|
0/038
|
Xu et al.
|
426
|
0
|
0
|
852
|
0
|
443
|
1
|
0
|
887
|
1
|
0/98
|
0/001
|
Bigdeli et al. [63]
|
150
|
30
|
20
|
330
|
70
|
192
|
8
|
0
|
392
|
8
|
0/77
|
0/02
|
Yengel et al.
|
130
|
1
|
14
|
261
|
29
|
102
|
0
|
3
|
204
|
6
|
0/65
|
0/394
|
- P-HWE p-value for Hardy–Weinberg equilibrium; MAF Minor allele frequency of control group